Stephen Mullennix serves as Executive at UroGen Pharma Ltd., where they oversee executive responsibilities. Since joining the company, Stephen Mullennix has executed 14 insider transactions totaling $203.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 27, 2020 involved selling 145 shares valued at $3.5K.
Stephen Mullennix currently holds 10,084 shares of UroGen Pharma Ltd. (URGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Mullennix has been a net seller of URGN stock. They have purchased $0 and sold $203.4K worth of shares.
Stephen Mullennix's most recent insider trade was on Apr 27, 2020, when they sold 145 shares at $24.35 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 14, 2020 | URGN | $0 | Option Exercise | 1,759 | $N/A | Discretionary |
| Feb 14, 2020 | URGN | $17.2K | Sale | 612 | $28.04 | Discretionary |
| Jan 27, 2020 | URGN | $20.0K | Sale | 684 | $29.26 | Discretionary |
| Jan 26, 2020 | URGN | $0 | Option Exercise | 1,666 | $N/A | Discretionary |
| Nov 14, 2019 | URGN | $15.8K | Sale | 608 | $26.00 | Discretionary |
| Nov 14, 2019 | URGN | $0 | Option Exercise | 1,759 | $N/A | Discretionary |
| Aug 15, 2019 | URGN | $19.2K | Sale | 608 | $31.65 | Discretionary |
| Aug 14, 2019 | URGN | $0 | Option Exercise | 1,759 | $N/A | Discretionary |
| May 14, 2019 | URGN | $23.1K | Sale | 608 | $37.98 | Discretionary |
| May 14, 2019 | URGN | $0 | Option Exercise | 1,759 | $N/A | Discretionary |
| Feb 14, 2019 | URGN | $0 | Option Exercise | 7,034 | $N/A | Discretionary |
| Feb 14, 2019 | URGN | $104.6K | Sale | 2,804 | $37.30 | Discretionary |